Failure Mode, Effects and Criticality Analysis (FMECA) as a means of improving the hospital drug prescribing process
作者： S. Saizy‐Callaert , C. Chouaïd , A. Thébault , R. Causse
DOI:
关键词:
摘要: Failure Mode, Effects and Criticality Analysis (FMECA) is used in industry to prevent process or product failures. We studied the feasibility of this method hospital environment. FMECA was improve drug prescription two medical wards. modes were identified classified hierarchically. Corrective actions taken. Involvement all professionals concerned secured, has resulted real acceptance proposed changes their effective realization.
参考文章(15)
Elizabeth Williams, R. Talley, The use of failure mode effect and criticality analysis in a medication error subcommittee. Hospital Pharmacy. ,vol. 29, pp. 331- ,(1994)
Davis Nm, Senders J, Cohen Mr, Failure mode and effects analysis: a novel approach to avoiding dangerous medication errors and accidents. Hospital Pharmacy. ,vol. 29, pp. 319- 330 ,(1994)
Sanford E. Feldman, Douglas W. Roblin, Medical Accidents in Hospital Care: Applications of Failure Analysis to Hospital Quality Appraisal The Joint Commission Journal on Quality Improvement. ,vol. 23, pp. 567- 580 ,(1997) , 10.1016/S1070-3241(16)30340-6
Sheng‐Hsien (Gary) Teng, Shin‐Yann (Michael) Ho, Failure mode and effects analysis: An integrated approach for product design and process control International Journal of Quality & Reliability Management. ,vol. 13, pp. 8- 26 ,(1996) , 10.1108/02656719610118151
O. Grandcourt, S. Callaert, C. Fuhrman, C. Chouaid, Assurance qualité à l’hôpital : comparaison de 3 circuitsdu médicament Journal de Pharmacie Clinique. ,vol. 19, pp. 143- 148 ,(2000)
Karen M. McNally, Maxwell A. Page, V. Bruce Sunderland, Failure-mode and effects analysis in improving a drug distribution system. American Journal of Health-system Pharmacy. ,vol. 54, pp. 171- 177 ,(1997) , 10.1093/AJHP/54.2.171
Stephen B Kritchevsky, Bryan P Simmons, Continuous quality improvement. Concepts and applications for physician care JAMA: The Journal of the American Medical Association. ,vol. 266, pp. 1817- 1823 ,(1991) , 10.1001/JAMA.266.13.1817
A. Marey, B. Coupez, L. Gruca, V. Vannier, P. Renom, B. Wibaut, L. Rugeri, C. Cossement, A. Cosson, Impact d'une démarche qualité en sécurité transfusionnelle sur la prescription, l'optimisation des circuits, la traçabilité Transfusion Clinique et Biologique. ,vol. 4, pp. 469- 484 ,(1997) , 10.1016/S1246-7820(97)80065-1
Glenn Laffel, The Case for Using Industrial Quality Management Science in Health Care Organizations JAMA: The Journal of the American Medical Association. ,vol. 262, pp. 2869- 2873 ,(1989) , 10.1001/JAMA.1989.03430200113036
E. Hergon, H. Crespeau, Ph. Rouger, Modes de défaillance du processus transfusionnel. Intérêt de l'analyse prévisionnelle de sûreté de fonctionnement Transfusion Clinique Et Biologique. ,vol. 1, pp. 379- 386 ,(1994) , 10.1016/S1246-7820(06)80020-0